tiprankstipranks
Zai Lab, Bristol Myers: Krazati confirmatory trial meets PFS primary endpoints
PremiumThe FlyZai Lab, Bristol Myers: Krazati confirmatory trial meets PFS primary endpoints
2M ago
Zai Lab says partner Novocure’s Phase 3 trial met primary endpoint
PremiumThe Fly
Zai Lab says partner Novocure’s Phase 3 trial met primary endpoint
2M ago
Zai Lab price target lowered to $66 from $123 at Citi
PremiumThe Fly
Zai Lab price target lowered to $66 from $123 at Citi
3M ago
Zai Lab weakness presents buying opportunity, says Cantor Fitzgerald
PremiumThe FlyZai Lab weakness presents buying opportunity, says Cantor Fitzgerald
3M ago
Zai Lab Secures Debt Facilities to Boost Capital Flexibility
PremiumCompany Announcements
Zai Lab Secures Debt Facilities to Boost Capital Flexibility
3M ago
Zai Lab management to meet with Cantor Fitzgerald
PremiumThe Fly
Zai Lab management to meet with Cantor Fitzgerald
3M ago
Zai Lab initiated with bullish view at Morgan Stanley, here’s why
PremiumThe FlyZai Lab initiated with bullish view at Morgan Stanley, here’s why
5M ago
Paratek announces inclusion of oral NUZYRA in China’s NRDL
PremiumThe Fly
Paratek announces inclusion of oral NUZYRA in China’s NRDL
5M ago
Zai Lab announces updates on China NRDL
PremiumThe Fly
Zai Lab announces updates on China NRDL
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100